Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-05-25 @ 12:55 AM
Study NCT ID:
NCT02411656
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-31
First Post:
2015-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Edema | View |
| None | Erythema | View |
| None | Estrogen Receptor Negative | View |
| None | HER2/Neu Negative | View |
| None | Peau d'Orange | View |
| None | Progesterone Receptor Negative | View |
| None | Recurrent Inflammatory Breast Carcinoma | View |
| None | Stage IV Inflammatory Breast Carcinoma | View |
| None | Triple-Negative Breast Carcinoma | View |
Keywords: